BiotechTube

Prednisolone

Phase 1Withdrawn
0 watching 0 views this week๐Ÿ’ค Quiet
33
Hype Score

Development Stage

โœ“
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Friedreich Ataxia

Conditions

Friedreich Ataxia, Cardiomyopathy

Trial Timeline

Nov 8, 2024 โ†’ Oct 22, 2025

NCT ID
NCT06483802

About Prednisolone

Prednisolone is a phase 1 stage product being developed by Astellas Pharma for Friedreich Ataxia. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT06483802. Target conditions include Friedreich Ataxia, Cardiomyopathy.

Hype Score Breakdown

Clinical
10
Activity
5
Company
10
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT06483802Phase 1Withdrawn

Competing Products

20 competing products in Friedreich Ataxia

See all competitors
ProductCompanyStageHype Score
Omaveloxolone Capsules, 2.5 mg + Omaveloxolone Capsules, 5 mg + Omaveloxolone Capsules, 10 mg + Placebo + Omaveloxolone Capsules, 20 mg + Omaveloxolone Capsules, 40 mg + Omaveloxolone Capsules, 80 mg + Omaveloxolone Capsules, 160 mg + Omaveloxolone Capsules, 300 mg + Omaveloxolone Capsules, 150 mgAbbViePhase 2
52
Interferon ฮณ-1bAmgenPhase 3
76
interferon ฮณ-1bAmgenPhase 3
76
Interferon ฮณ-1b + PlaceboAmgenPhase 3
76
varenicline + placeboPfizerPhase 2/3
64
Lu AA24493 + PlaceboLundbeckPhase 2
49
OmaveloxoloneBiogenPre-clinical
20
OmaveloxoloneBiogenPhase 1
30
OmaveloxoloneBiogenPre-clinical
20
Omaveloxolone + PlaceboBiogenPhase 3
74
OmeveloxoloneBiogenPre-clinical
20
TAK-831 + TAK-831 PlaceboNeurocrine BiosciencesPhase 2
49
EGb 761 120 mg + PlaceboIpsenPhase 2
49
Vatiquinone + PlaceboPTC TherapeuticsPhase 2/3
62
Placebo + EPI-743 400 mg + EPI-743 200 mgPTC TherapeuticsPhase 2
49
VatiquinonePTC TherapeuticsPhase 2
49
VatiquinonePTC TherapeuticsPhase 3
74
DT-216 + PlaceboDesign TherapeuticsPhase 1
28
DT-216P2 + SalineDesign TherapeuticsPhase 1
28
DT-216 + DT-216 matching PlaceboDesign TherapeuticsPhase 1
28

Other Products from Astellas Pharma

Tacrolimus, PrografยฎApproved
85
micafungin + voriconazoleApproved
85
mirabegron + solifenacinApproved
85
Zolpidem (Mysleeยฎ) + placeboApproved
85
TacrolimusApproved
85